Form 8-K · Current report
Becton Dickinson 8-K, filed Nov 5, 2026
- Filed
- CIK
- 0000010795
- Accession no.
- 0001628280-26-070511
Summary
Becton Dickinson reported fourth-quarter fiscal 2026 revenue of $5.3 billion, up 5.4%, and full-year revenue of $19.5 billion, and guided fiscal 2027 to adjusted diluted EPS of $13.10 to $13.30. Chief executive Tom Polen called fiscal 2026 a defining year following the completed spin-off of the Life Sciences business, and the company announced a partnership with the U.S. government under which it intends to invest $19 billion in the U.S., including $3 billion in manufacturing expansion, with relief from future Section 232 tariffs on covered products subject to final scope and milestones.
Key points
- Becton Dickinson reported fourth-quarter fiscal 2026 revenue of $5.27 billion, up 5.4% as reported and 5.6% currency-neutral, with GAAP diluted EPS of $2.52 and adjusted diluted EPS of $4.15.
- Full-year fiscal 2026 revenue was $19.5 billion, up 4.9%, with GAAP diluted EPS of $5.06 and adjusted diluted EPS of $12.70; cash from continuing operations rose 30% to $3.6 billion and free cash flow rose 42.5% to $2.9 billion.
- Becton Dickinson guided fiscal 2027 to low single-digit revenue growth and adjusted diluted EPS of $13.10 to $13.30.
- The company completed the spin-off of its former Biosciences and Diagnostic Solutions business and its combination with Waters Corporation on February 9, 2026, and will hold an Investor Day on December 10 at the New York Stock Exchange.
Written by an AI model from the filing text. It can be incomplete or wrong; the filing on SEC.gov is the record.
Items reported
- 2.02Results of Operations and Financial Condition
- 9.01Financial Statements and Exhibits
From the filing
ITEM 2.02 RESULTS OF OPERATIONS AND FINANCIAL CONDITION. On November 5, 2026, Becton, Dickinson and Company (“BD”) issued a press release announcing its financial results for its fourth fiscal quarter ending September 30, 2026. A copy of the press release is furnished as Exhibit 99.1 to this report. The press release furnished as Exhibit 99.1 contains certain financial measures that differ from those presented in accordance with U.S. generally accepted accounting principles (“non-GAAP measures”). Details regarding these non-GAAP measures and adjustments can be found in the schedules included in the press release furnished as Exhibit 99.1. ITEM 9.01 FINANCIAL STATEMENTS AND EXHIBITS. …
An excerpt of the text as filed with the SEC, cut for length.
Readster writes AI-generated summaries of public filings for research purposes only. Summaries can be incomplete or wrong — check the original filing on SEC.gov before relying on it. Nothing here is investment, legal or medical advice.